FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104289320> ?p ?o ?g. }

• W2104289320 endingPage "S42" @default.
• W2104289320 startingPage "S42" @default.
• W2104289320 abstract "C/EBPalpha (42 kDa) is commonly dysregulated in acute myeloid leukaemia (AML) by mutation or via the action of AML oncogenes, which can increase the 30 kDa protein oncogenic form of C/EBPalpha (p30). The Trib2 oncogene is associated with dysregulated C/EBPalpha in human AML and leads to the degradation of p42, leaving p30 intact. Indeed there exists a novel paradigm whereby an E2F1-p30-Trib2 positive regulatory loop and an E2F1-p42-Trib2 negative feedback loop plays a key role in Trib2 expression, essential for AML cell proliferation and survival. Thus, it is important to understand the Trib2-C/EBPalpha relationship in the context of p42 degradation and/or C/EBPalpha mutation in AML.Using mouse genetics our data reveals that in the absence of C/EBPalpha (-/-) Trib2 was unable to induce AML whereas in the presence of p42 and mutant p30 (L/+), Trib2 and p30 cooperate to decrease the latency of AML disease. In the situation where p30 is expressed in the absence of p42, which alone can lead to AML (L/L), Trib2 does not lead to a more aggressive disease than that caused by p30 itself. These data show that the modulation of p42 rather than the expression of p30 is a key driver in Trib2 AML. Peptide array analysis showed the site-specific direct interaction between Trib2 and p42, and mutational analysis showed that these site-specific interactions were required for the K48-specific ubiquitin-dependent proteasomal degradation of p42. A C-terminal lysine residue of C/EBPalpha commonly found duplicated in AML patients was critical for Trib2-mediated p42 ubiquitination and proteasomal degradation. Proteasome inhibition using bortezomib induced cell death in Trib2 positive AML cell lines and AML patient samples in vitro and in vivo. Knockdown and overexpression of Trib2 in AML cells followed by transplantation in NSG mice and treated with bortezomib selectively killed Trib2 positive AML. Our data show the mechanism required for oncogene function centres on p42 degradation. C/EBPalpha (42 kDa) is commonly dysregulated in acute myeloid leukaemia (AML) by mutation or via the action of AML oncogenes, which can increase the 30 kDa protein oncogenic form of C/EBPalpha (p30). The Trib2 oncogene is associated with dysregulated C/EBPalpha in human AML and leads to the degradation of p42, leaving p30 intact. Indeed there exists a novel paradigm whereby an E2F1-p30-Trib2 positive regulatory loop and an E2F1-p42-Trib2 negative feedback loop plays a key role in Trib2 expression, essential for AML cell proliferation and survival. Thus, it is important to understand the Trib2-C/EBPalpha relationship in the context of p42 degradation and/or C/EBPalpha mutation in AML. Using mouse genetics our data reveals that in the absence of C/EBPalpha (-/-) Trib2 was unable to induce AML whereas in the presence of p42 and mutant p30 (L/+), Trib2 and p30 cooperate to decrease the latency of AML disease. In the situation where p30 is expressed in the absence of p42, which alone can lead to AML (L/L), Trib2 does not lead to a more aggressive disease than that caused by p30 itself. These data show that the modulation of p42 rather than the expression of p30 is a key driver in Trib2 AML. Peptide array analysis showed the site-specific direct interaction between Trib2 and p42, and mutational analysis showed that these site-specific interactions were required for the K48-specific ubiquitin-dependent proteasomal degradation of p42. A C-terminal lysine residue of C/EBPalpha commonly found duplicated in AML patients was critical for Trib2-mediated p42 ubiquitination and proteasomal degradation. Proteasome inhibition using bortezomib induced cell death in Trib2 positive AML cell lines and AML patient samples in vitro and in vivo. Knockdown and overexpression of Trib2 in AML cells followed by transplantation in NSG mice and treated with bortezomib selectively killed Trib2 positive AML. Our data show the mechanism required for oncogene function centres on p42 degradation." @default.
• W2104289320 created "2016-06-24" @default.
• W2104289320 creator A5013724666 @default.
• W2104289320 creator A5021972507 @default.
• W2104289320 creator A5029863354 @default.
• W2104289320 creator A5038292671 @default.
• W2104289320 creator A5043119611 @default.
• W2104289320 creator A5043134223 @default.
• W2104289320 creator A5045126068 @default.
• W2104289320 creator A5055586974 @default.
• W2104289320 creator A5071398590 @default.
• W2104289320 creator A5087281690 @default.
• W2104289320 date "2014-08-01" @default.
• W2104289320 modified "2023-10-18" @default.
• W2104289320 title "Targeting C/EBPalpha p42 and oncogene cooperativity in acute myeloid leukaemia" @default.
• W2104289320 doi "https://doi.org/10.1016/j.exphem.2014.07.153" @default.
• W2104289320 hasPublicationYear "2014" @default.
• W2104289320 type Work @default.
• W2104289320 sameAs 2104289320 @default.
• W2104289320 citedByCount "0" @default.
• W2104289320 crossrefType "journal-article" @default.
• W2104289320 hasAuthorship W2104289320A5013724666 @default.
• W2104289320 hasAuthorship W2104289320A5021972507 @default.
• W2104289320 hasAuthorship W2104289320A5029863354 @default.
• W2104289320 hasAuthorship W2104289320A5038292671 @default.
• W2104289320 hasAuthorship W2104289320A5043119611 @default.
• W2104289320 hasAuthorship W2104289320A5043134223 @default.
• W2104289320 hasAuthorship W2104289320A5045126068 @default.
• W2104289320 hasAuthorship W2104289320A5055586974 @default.
• W2104289320 hasAuthorship W2104289320A5071398590 @default.
• W2104289320 hasAuthorship W2104289320A5087281690 @default.
• W2104289320 hasConcept C104317684 @default.
• W2104289320 hasConcept C143065580 @default.
• W2104289320 hasConcept C1491633281 @default.
• W2104289320 hasConcept C151730666 @default.
• W2104289320 hasConcept C153911025 @default.
• W2104289320 hasConcept C185592680 @default.
• W2104289320 hasConcept C2779282312 @default.
• W2104289320 hasConcept C2779343474 @default.
• W2104289320 hasConcept C2781018059 @default.
• W2104289320 hasConcept C29537977 @default.
• W2104289320 hasConcept C501734568 @default.
• W2104289320 hasConcept C502942594 @default.
• W2104289320 hasConcept C54355233 @default.
• W2104289320 hasConcept C81885089 @default.
• W2104289320 hasConcept C86339819 @default.
• W2104289320 hasConcept C86803240 @default.
• W2104289320 hasConcept C95444343 @default.
• W2104289320 hasConcept C97037327 @default.
• W2104289320 hasConceptScore W2104289320C104317684 @default.
• W2104289320 hasConceptScore W2104289320C143065580 @default.
• W2104289320 hasConceptScore W2104289320C1491633281 @default.
• W2104289320 hasConceptScore W2104289320C151730666 @default.
• W2104289320 hasConceptScore W2104289320C153911025 @default.
• W2104289320 hasConceptScore W2104289320C185592680 @default.
• W2104289320 hasConceptScore W2104289320C2779282312 @default.
• W2104289320 hasConceptScore W2104289320C2779343474 @default.
• W2104289320 hasConceptScore W2104289320C2781018059 @default.
• W2104289320 hasConceptScore W2104289320C29537977 @default.
• W2104289320 hasConceptScore W2104289320C501734568 @default.
• W2104289320 hasConceptScore W2104289320C502942594 @default.
• W2104289320 hasConceptScore W2104289320C54355233 @default.
• W2104289320 hasConceptScore W2104289320C81885089 @default.
• W2104289320 hasConceptScore W2104289320C86339819 @default.
• W2104289320 hasConceptScore W2104289320C86803240 @default.
• W2104289320 hasConceptScore W2104289320C95444343 @default.
• W2104289320 hasConceptScore W2104289320C97037327 @default.
• W2104289320 hasIssue "8" @default.
• W2104289320 hasLocation W21042893201 @default.
• W2104289320 hasOpenAccess W2104289320 @default.
• W2104289320 hasPrimaryLocation W21042893201 @default.
• W2104289320 hasRelatedWork W101124211 @default.
• W2104289320 hasRelatedWork W1697597638 @default.
• W2104289320 hasRelatedWork W2009647017 @default.
• W2104289320 hasRelatedWork W2076039769 @default.
• W2104289320 hasRelatedWork W2188225473 @default.
• W2104289320 hasRelatedWork W2613842309 @default.
• W2104289320 hasRelatedWork W2670772823 @default.
• W2104289320 hasRelatedWork W2807870374 @default.
• W2104289320 hasRelatedWork W2887661769 @default.
• W2104289320 hasRelatedWork W4386917719 @default.
• W2104289320 hasVolume "42" @default.
• W2104289320 isParatext "false" @default.
• W2104289320 isRetracted "false" @default.
• W2104289320 magId "2104289320" @default.
• W2104289320 workType "article" @default.